PMC:7534795 / 110759-111110 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T61","span":{"begin":157,"end":165},"obj":"Body_part"},{"id":"T62","span":{"begin":238,"end":246},"obj":"Body_part"}],"attributes":[{"id":"A61","pred":"fma_id","subj":"T61","obj":"http://purl.org/sig/ont/fma/fma62851"},{"id":"A62","pred":"fma_id","subj":"T62","obj":"http://purl.org/sig/ont/fma/fma63891"}],"text":"rognosis in severe SARS-CoV-2 infected patients (Tang, Bai, et al., 2020).\nN-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redf"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T610","span":{"begin":19,"end":27},"obj":"Disease"}],"attributes":[{"id":"A610","pred":"mondo_id","subj":"T610","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"rognosis in severe SARS-CoV-2 infected patients (Tang, Bai, et al., 2020).\nN-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redf"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T126","span":{"begin":166,"end":176},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T127","span":{"begin":238,"end":246},"obj":"http://purl.obolibrary.org/obo/CHEBI_3815"}],"text":"rognosis in severe SARS-CoV-2 infected patients (Tang, Bai, et al., 2020).\nN-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redf"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T40880","span":{"begin":79,"end":84},"obj":"Chemical"},{"id":"T56258","span":{"begin":99,"end":105},"obj":"Chemical"},{"id":"T81371","span":{"begin":157,"end":183},"obj":"Chemical"},{"id":"T47565","span":{"begin":252,"end":261},"obj":"Chemical"},{"id":"T76873","span":{"begin":262,"end":273},"obj":"Chemical"}],"attributes":[{"id":"A93928","pred":"chebi_id","subj":"T40880","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"},{"id":"A27839","pred":"chebi_id","subj":"T56258","obj":"http://purl.obolibrary.org/obo/CHEBI_18059"},{"id":"A37424","pred":"chebi_id","subj":"T81371","obj":"http://purl.obolibrary.org/obo/CHEBI_36707"},{"id":"A48140","pred":"chebi_id","subj":"T81371","obj":"http://purl.obolibrary.org/obo/CHEBI_44811"},{"id":"A63095","pred":"chebi_id","subj":"T81371","obj":"http://purl.obolibrary.org/obo/CHEBI_52450"},{"id":"A69244","pred":"chebi_id","subj":"T47565","obj":"http://purl.obolibrary.org/obo/CHEBI_16335"},{"id":"A46647","pred":"chebi_id","subj":"T76873","obj":"http://purl.obolibrary.org/obo/CHEBI_18361"},{"id":"A89803","pred":"chebi_id","subj":"T76873","obj":"http://purl.obolibrary.org/obo/CHEBI_33019"}],"text":"rognosis in severe SARS-CoV-2 infected patients (Tang, Bai, et al., 2020).\nN-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redf"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T28","span":{"begin":157,"end":176},"obj":"http://purl.obolibrary.org/obo/GO_0030168"}],"text":"rognosis in severe SARS-CoV-2 infected patients (Tang, Bai, et al., 2020).\nN-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redf"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T251","span":{"begin":12,"end":38},"obj":"Phenotype"}],"attributes":[{"id":"A251","pred":"hp_id","subj":"T251","obj":"http://purl.obolibrary.org/obo/HP_0033141"}],"text":"rognosis in severe SARS-CoV-2 infected patients (Tang, Bai, et al., 2020).\nN-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redf"}

{"project":"2_test","denotations":[{"id":"33031856-32220112-84039141","span":{"begin":68,"end":72},"obj":"32220112"},{"id":"33031856-32270798-84039142","span":{"begin":290,"end":294},"obj":"32270798"}],"text":"rognosis in severe SARS-CoV-2 infected patients (Tang, Bai, et al., 2020).\nN-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redf"}

{"project":"LitCovid-PubTator","denotations":[{"id":"3108","span":{"begin":39,"end":47},"obj":"Species"},{"id":"3121","span":{"begin":19,"end":38},"obj":"Disease"},{"id":"3149","span":{"begin":228,"end":236},"obj":"Gene"},{"id":"3152","span":{"begin":252,"end":261},"obj":"Chemical"}],"attributes":[{"id":"A3108","pred":"tao:has_database_id","subj":"3108","obj":"Tax:9606"},{"id":"A3121","pred":"tao:has_database_id","subj":"3121","obj":"MESH:C000657245"},{"id":"A3149","pred":"tao:has_database_id","subj":"3149","obj":"Gene:2147"},{"id":"A3152","pred":"tao:has_database_id","subj":"3152","obj":"MESH:D000241"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"rognosis in severe SARS-CoV-2 infected patients (Tang, Bai, et al., 2020).\nN-3 PUFAs contain polar lipids that exhibit potent antithrombotic effects against platelet-activating factor and other prothrombotic pathways, including thrombin, collagen, and adenosine diphosphate (Lordan et al., 2020; Tsoupras et al., 2019; Tsoupras, O'Keeffe, Lordan, Redf"}